131 related articles for article (PubMed ID: 12582447)
21. Short Term Effects of Tiotropium on COPD Patients Treated with Long Acting Bronchodilators.
Nicolini A
Tanaffos; 2012; 11(1):26-31. PubMed ID: 25191397
[TBL] [Abstract][Full Text] [Related]
22. Investigating the Unbinding of Muscarinic Antagonists from the Muscarinic 3 Receptor.
Buigues PJ; Gehrke S; Badaoui M; Dudas B; Mandana G; Qi T; Bottegoni G; Rosta E
J Chem Theory Comput; 2023 Aug; 19(15):5260-5272. PubMed ID: 37458730
[TBL] [Abstract][Full Text] [Related]
23. In vitro anticholinergic drugs affect CD8+ peripheral blood T-cells apoptosis in COPD.
Profita M; Riccobono L; Montalbano AM; Bonanno A; Ferraro M; Albano GD; Gerbino S; Casarosa P; Pieper MP; Gjomarkaj M
Immunobiology; 2012 Mar; 217(3):345-53. PubMed ID: 21855166
[TBL] [Abstract][Full Text] [Related]
24. Simultaneous quantification of tiotropium bromide impurities G + H in capsule formulation by LC-MS/MS.
Erkol S; Güleli M; Çalışkan C; Kocaoba S
Eur J Mass Spectrom (Chichester); 2024 Feb; 30(1):76-83. PubMed ID: 38037337
[TBL] [Abstract][Full Text] [Related]
25. Patient-reported outcomes and considerations in the management of COPD: focus on aclidinium.
Lopez-Campos JL; Calero C; Lopez-Ramirez C; Asensio-Cruz MI; Márquez-Martín E; Ortega-Ruiz F
Patient Prefer Adherence; 2015; 9():95-104. PubMed ID: 25653503
[TBL] [Abstract][Full Text] [Related]
26. Gender-related Responsiveness to the Pharmacological Treatment of COPD: A First Step Towards the Personalized Medicine.
Calzetta L; Puxeddu E; Rogliani P
EBioMedicine; 2017 May; 19():14-15. PubMed ID: 28473238
[TBL] [Abstract][Full Text] [Related]
27. Computer-aided design of muscarinic acetylcholine receptor M3 inhibitors: Promising compounds among trifluoromethyl containing hexahydropyrimidinones/thiones.
Nyporko A; Tsymbalyuk O; Voiteshenko I; Starosyla S; Protopopov M; Bdzhola V
Mol Inform; 2023 Aug; 42(8-9):e2300006. PubMed ID: 37293808
[TBL] [Abstract][Full Text] [Related]
28. Aclidinium bromide inhalation powder (tudorza): a long-acting anticholinergic for the management of chronic obstructive pulmonary disease.
Pisano M; Mazzola N
P T; 2013 Jul; 38(7):393-6. PubMed ID: 24049425
[TBL] [Abstract][Full Text] [Related]
29. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.
Keam SJ; Keating GM
Treat Respir Med; 2004; 3(4):247-68. PubMed ID: 15350163
[TBL] [Abstract][Full Text] [Related]
30. Tiotropium bromide: a new long-acting bronchodilator for the treatment of chronic obstructive pulmonary disease.
Koumis T; Samuel S
Clin Ther; 2005 Apr; 27(4):377-92. PubMed ID: 15922812
[TBL] [Abstract][Full Text] [Related]
31. Roles of airway smooth muscle dysfunction in chronic obstructive pulmonary disease.
Yan F; Gao H; Zhao H; Bhatia M; Zeng Y
J Transl Med; 2018 Sep; 16(1):262. PubMed ID: 30257694
[TBL] [Abstract][Full Text] [Related]
32. Inhaled glycopyrrolate for the treatment of chronic obstructive pulmonary disease.
Tashkin DP; Gross NJ
Int J Chron Obstruct Pulmon Dis; 2018; 13():1873-1888. PubMed ID: 29928118
[TBL] [Abstract][Full Text] [Related]
33. Role of nebulized glycopyrrolate in the treatment of chronic obstructive pulmonary disease.
Santus P; Radovanovic D; Cristiano A; Valenti V; Rizzi M
Drug Des Devel Ther; 2017; 11():3257-3271. PubMed ID: 29180850
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of nebulized glycopyrrolate for administration using a high efficiency nebulizer in patients with chronic obstructive pulmonary disease.
Leaker BR; Barnes PJ; Jones CR; Tutuncu A; Singh D
Br J Clin Pharmacol; 2015 Mar; 79(3):492-500. PubMed ID: 25243340
[TBL] [Abstract][Full Text] [Related]
35. Tiotropium increases cytosolic muscarinic M3 receptors and acetylated H3 histone proteins in induced sputum cells of COPD patients.
Holownia A; Mroz RM; Skopinski T; Kielek A; Kolodziejczyk A; Chyczewska E; Braszko JJ
Eur J Med Res; 2010 Nov; 15 Suppl 2(Suppl 2):64-7. PubMed ID: 21147623
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
